UM

Browse/Search Results:  1-5 of 5 Help

Selected(0)Clear Items/Page:    Sort:
A Proresolving Peptide Nanotherapy for Site-Specific Treatment of Inflammatory Bowel Disease by Regulating Proinflammatory Microenvironment and Gut Microbiota Journal article
ADVANCED SCIENCE, 2019,Volume: 6,Issue: 18
Authors:  Chenwen Li;  Yang Zhao;  Juan Cheng;  Jiawei Guo;  Qixiong Zhang;  Xiangjun Zhang;  Jiong Ren;  Fengchao Wang;  Jun Huang;  Houyuan Hu;  Ruibing Wang;  Jianxiang Zhang
Favorite | View/Download:9/0 | TC[WOS]:4 TC[Scopus]:0 | Submit date:2020/04/02
Colitis Targeting  Gut Microbiota  Nanotherapy  Proresolving Peptide  Reactive Oxygen Species  
Application of Nanoparticles for Targeting G Protein-Coupled Receptors Journal article
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2018,Volume: 19,Issue: 7
Authors:  Ma, Xin;  Xiong, Yunfang;  Lee, Leo Tsz On
Favorite | View/Download:22/0 | TC[WOS]:11 TC[Scopus]:0 | Submit date:2018/10/30
g Protein-coupled Receptor (Gpcr)  Cancer  Nanoparticles (Nps)  Dendrimers  Quantum Dots (Qds)  Gold Nanoparticles (Aunps)  Magnetic Nanoparticles (Mnps)  
Non-proinflammatory and responsive nanoplatforms for targeted treatment of atherosclerosis Journal article
Biomaterials, 2017,Volume: 143,Page: 93-108
Authors:  Dou Y.;  Chen Y.;  Zhang X.;  Xu X.;  Chen Y.;  Guo J.;  Zhang D.;  Wang R.;  Li X.;  Zhang J.
Favorite | View/Download:9/0 | TC[WOS]:0 TC[Scopus]:0 | Submit date:2018/11/06
Atherosclerosis  Inflammation  Responsive Nanotherapy  Reactive Oxygen Species  Targeting  Cyclodextrin Materials  
A superoxide dismutase/catalase mimetic nanomedicine for targeted therapy of inflammatory bowel disease Journal article
Biomaterials, 2016,Volume: 105,Page: 206-221
Authors:  Zhang Q.;  Tao H.;  Lin Y.;  Hu Y.;  An H.;  Zhang D.;  Feng S.;  Hu H.;  Wang R.;  Li X.;  Zhang J.
Favorite | View/Download:6/0 | TC[WOS]:44 TC[Scopus]:0 | Submit date:2018/11/06
Colitis  Cyclodextrin  Drug Delivery  Reactive Oxygen Species  Responsive Nanoparticles  Targeted Therapy  
Sustained delivery by a cyclodextrin material-based nanocarrier potentiates antiatherosclerotic activity of rapamycin via selectively inhibiting mTORC1 in mice Journal article
Journal of Controlled Release, 2016,Volume: 235,Page: 48-62
Authors:  Dou Y.;  Guo J.;  Chen Y.;  Han S.;  Xu X.;  Shi Q.;  Jia Y.;  Liu Y.;  Deng Y.;  Wang R.;  Li X.;  Zhang J.
Favorite | View/Download:6/0 | TC[WOS]:17 TC[Scopus]:0 | Submit date:2018/11/06
Atherosclerosis  Cyclodextrin  Mtor  Nanomedicine  Rapamycin  Sustained Delivery